Renal carcinoma cell line and uses thereof
Abstract
The present invention relates to a renal carcinoma cell line capable of activating the immune system in an antigen-specific manner. According to a further aspect, the invention also includes derivatives of the cell line that maintain said activation capacity. The invention also comprises a method for targeting and activating immune system cells against cells of clear cell renal carcinoma. Said method comprises the co-incubation of isolated immune system cells (dendritic cells, CD4*, CD8* lymphocytes etc.) with cells of the RCC BA85#21 line in accordance with the invention in a suitable culture medium, for a time sufficient to obtain antigen specific cells.
Classe Tecnologica
A - Human Necessities
Patent Office
United States Patent and Trademark Office
Numero Deposito
US8128923
Anno Deposito
2005
Anno Concessione
2006
Inventori Pugliesi
Tutti gli inventori
- Elena Ranieri
- Michele Battaglia
- Herr Wolfgang
- Loreto Gesualdo
Titolari pugliesi
Tutti i titolari
- Università Degli Studi Di Bari Aldo Moro
- Università Degli Studi Di Foggia
Condividi questo sito sui social